These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Studies on the activation mechanism of fibrinolytic enzyme system in plasma by human pancreatic elastase. Toki N; Takasugi S; Ishizu K; Sato H; Sumi H Thromb Haemost; 1982 Feb; 47(1):8-13. PubMed ID: 6176043 [TBL] [Abstract][Full Text] [Related]
23. Alpha 2-antiplasmin: functional characterization and metabolism in a heterozygote deficient patient. Knot EA; ten Cate JW; Lamping RJ; Gie LK Thromb Haemost; 1986 Jun; 55(3):375-8. PubMed ID: 3750266 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and secretion of the fibrinolytic components, including alpha 2-antiplasmin, by a human hepatoma cell line. Fair DS; Plow EF J Lab Clin Med; 1983 Mar; 101(3):372-84. PubMed ID: 6186756 [TBL] [Abstract][Full Text] [Related]
25. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation. Kassam G; Le BH; Choi KS; Kang HM; Fitzpatrick SL; Louie P; Waisman DM Biochemistry; 1998 Dec; 37(48):16958-66. PubMed ID: 9836589 [TBL] [Abstract][Full Text] [Related]
26. [Inhibition of the process of Glu-plasminogen activation by tissue activator with fibrin, DDE-complex, and D-dimer using alpha-2-antiplasmin]. Hrynenko TV; Zadorozhna MB; Platonova TM; Volkov HL Ukr Biokhim Zh (1999); 2005; 77(5):45-51. PubMed ID: 16846069 [TBL] [Abstract][Full Text] [Related]
27. [Regulation with alpha-2-antiplasmin of Glu-plasminogen activation by tissue activator on fibrin]. Hrynenko TV; Zadorozhna MB; Iusova OI Ukr Biokhim Zh (1999); 2006; 78(3):106-12. PubMed ID: 17100317 [TBL] [Abstract][Full Text] [Related]
28. Structures of importance for the stability of antiplasmin as studied by site-directed mutagenesis. Wang H; Pap S; Wiman B Thromb Res; 2006; 117(3):315-22. PubMed ID: 16378834 [TBL] [Abstract][Full Text] [Related]
29. [Effect of venous stasis on plasminogen activation and plasma alpha 2-antiplasmin levels in type II diabetes mellitus]. Longoni P; Montani N; Gangale MG; Gamba G Recenti Prog Med; 1987; 78(7-8):323-7. PubMed ID: 3423401 [No Abstract] [Full Text] [Related]
30. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface. Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615 [TBL] [Abstract][Full Text] [Related]
31. [Effect of streptokinase on the interaction of alpha-2-antiplasmin with different sites of plasmin molecule]. Iusova EI; Grinenko TV; Volkov GL Ukr Biokhim Zh (1999); 2004; 76(2):98-106. PubMed ID: 15915719 [TBL] [Abstract][Full Text] [Related]
32. Effects of fibrin and alpha2-antiplasmin on plasminogen activation by staphylokinase. Okada K; Ueshima S; Takaishi T; Yuasa H; Fukao H; Matsuo O Am J Hematol; 1996 Nov; 53(3):151-7. PubMed ID: 8895684 [TBL] [Abstract][Full Text] [Related]
33. Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin. Rijken DC; Groeneveld E; Kluft C; Nieuwenhuis HK Biochem J; 1988 Oct; 255(2):609-15. PubMed ID: 2974279 [TBL] [Abstract][Full Text] [Related]
34. Definition of the structural elements in plasminogen required for high-affinity binding to apolipoprotein(a): a study utilizing surface plasmon resonance. Hancock MA; Spencer CA; Koschinsky ML Biochemistry; 2004 Sep; 43(38):12237-48. PubMed ID: 15379562 [TBL] [Abstract][Full Text] [Related]
35. Activities of antiplasmin and antiplasminogen activator in serous middle ear effusions. Hamaguchi Y; Ohi M; Sakakura Y; Miyoshi Y Ann Otol Rhinol Laryngol; 1985; 94(3):293-6. PubMed ID: 3925865 [TBL] [Abstract][Full Text] [Related]